News - Crestor

Filter

Current filters:

Crestor

Popular Filters

AstraZeneca and Shionogi settle Crestor arbitration

AstraZeneca and Shionogi settle Crestor arbitration

26-12-2013

Anglo-Swedish drug major AstraZeneca revealed yesterday (December 26) the full resolution of arbitration…

Asia-PacificAstraZenecaCardio-vascularCrestorGlobalLicensingPharmaceuticalShionogi

New ACC and AHA guidelines could increase sales of statins

New ACC and AHA guidelines could increase sales of statins

13-11-2013

New clinical guidelines have been published for the treatment of cholesterol in people at high risk of…

AbbVieAstraZenecaCardio-vascularCrestorHealthcareLipitorMerck & CoNorth AmericaPfizerPharmaceuticalTricorUSAZetia

AstraZeneca target Omthera files for US approval of Epanova

09-07-2013

Emerging US specialty pharmaceutical company Omthera Pharmaceuticals (Nasdaq: OMTH) today (July 9) announced…

AstraZenecaCardio-vascularCrestorEpanovaOmthera PharmaceuticalsPharmaceutical

AstraZeneca in Crestor patent settlement with Actavis and EGIS Pharma

25-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a settlement agreement in its US patent…

ActavisCardio-vascularCrestorGenericsNorth AmericaPatentsPharmaceuticalrosuvastatinShionogiWatson Pharmaceuticals

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

AstraZeneca's Crestor patent rule invalid in Australia

05-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that the Federal Court of Australia…

Asia-PacificAstraZenecaCardio-vascularCrestorPatentsPharmaceutical

New study reinforces the differentiating benefits of AstraZeneca's Crestor

29-05-2012

Data presented yesterday at the 2012 European Atherosclerosis Society (EAS) Congress in Milan, Italy,…

AstraZenecaCardio-vascularCrestorPharmaceuticalResearch

FDA expands on cholesterol-lowering drug risks

29-02-2012

Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins…

AstraZenecaCardio-vascularCrestorLipitorMerck & CoNorth AmericaPfizerPharmaceuticalRegulationZocor

Mixed results for AstraZeneca in study comparing Crestor with Lipitor

16-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) presented mixed results from a study comparing its cholesterol…

AstraZenecaCardio-vascularCrestorLipitorPfizerPharmaceuticalResearch

AstraZeneca launches new Crestor savings card in USA, as generic Lipitor about to debut

07-11-2011

The US subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched a new savings…

AstraZenecaCardio-vascularCrestorGenericsLipitorNorth AmericaPfizerPharmaceuticalPricing

AstraZeneca’s Crestor fails to show significant improvement over Lipitor

05-09-2011

There was a big disappointment for Anglo-Swedish drug major AstraZeneca (LSE: AZN) on Friday, when it…

AstraZenecaCardio-vascularCrestorLipitorPfizerPharmaceuticalResearch

Tentative OK from US FDA for Watson's rosuvastatin zinc tablets

10-08-2011

US drugmaker Watson Pharmaceuticals (NYSE: WPI) says that its subsidiary, Watson Laboratories, has received…

AstraZenecaCardio-vascularCrestorGenericsNorth AmericaRegulationrosuvastatinWatson Pharmaceuticals

Back to top